Telix Pharmaceuticals Ltd (TLX.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8,906 | -6,594 | -4,788 | -971 | -191 |
| Net Acquisitions | -21,574 | N/A | -662 | N/A | -248 |
| Purchase Of Investment | -32,328 | -8,963 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -12,256 | -760 | -4,642 | N/A | -57 |
| Other Investing Activity | -8,991 | -1,049 | -1,471 | -1,005 | -344 |
| Investing Cash Flow | $-84,054 | $-17,366 | $-11,563 | $-1,976 | $-839 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 407,881 | 3,922 | 2,050 | N/A | N/A |
| Debt Repayment | -1,946 | N/A | -9 | -246 | -309 |
| Common Stock Issued | 621 | 4,532 | 123,161 | 2,742 | 27,026 |
| Other Financing Activity | -9,255 | -1,514 | -6,177 | -432 | -486 |
| Financing Cash Flow | $397,301 | $6,940 | $119,025 | $2,063 | $26,231 |
| Exchange Rate Effect | 25,078 | -1,140 | 203 | 2,392 | -1,260 |
| Beginning Cash Position | 76,632 | 79,255 | 14,992 | 56,503 | 34,290 |
| End Cash Position | 441,714 | 83,961 | 79,139 | 15,975 | 59,929 |
| Net Cash Flow | $340,003 | $5,846 | $63,943 | $-42,921 | $26,899 |
| Free Cash Flow | |||||
| Capital Expenditure | -21,162 | -7,354 | -9,430 | -971 | -248 |
| Free Cash Flow | -21,162 | -7,354 | -9,430 | -971 | -248 |